Sleep in Adolescents and Young Adults in the Year after Cancer Treatment

Lauren Daniel, Richa Aggarwal, Lisa A. Schwartz

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Purpose: Adolescents and young adults (AYA) with cancer are a vulnerable group facing more intense treatments, higher symptom burden, and poorer treatment outcomes relative to younger children. Sleep disruption is common during cancer treatment and sleep problems persist into adulthood for some survivors of AYA cancer. The developmental period of adolescence/emerging adulthood confers greater biological and behavioral risk for insufficient sleep relative to older or younger ages. Thus, understanding AYA sleep disturbances shortly after completing treatment can inform interventions to manage cancer-related symptoms and improve quality of life. Methods: Sixty-one AYA (ages 12-25) within 1 year of finishing cancer treatment completed the Pittsburgh Sleep Quality Index (PSQI) and the Minneapolis-Manchester Quality of Life Instrument-Adolescent Form. Treatment variables were extracted from electronic medical records. Results: Forty-seven percent of participants were classified as "poor sleepers," 41% reported prolonged sleep onset latency (>30 minutes), 31% reported sleep efficiency suggestive of insomnia, and 33% slept <8 hours nightly. Age moderated the relationship between time off treatment and PSQI total score: for younger AYA the relationship was positive and for older AYA the relationship was negative. Better sleep and higher quality of life were strongly related (r =-0.57, p < 0.001). Conclusions: For almost half of AYA cancer survivors studied, sleep is disrupted as indicated by long sleep-onset latencies, sleep efficiency suggestive of insomnia, and inadequate total sleep time. Screening for sleep disturbances after AYA complete cancer therapy may reduce the impact of sleep on quality of life and identify those at risk for insomnia.

Original languageEnglish (US)
Pages (from-to)560-567
Number of pages8
JournalJournal of Adolescent and Young Adult Oncology
Volume6
Issue number4
DOIs
StatePublished - Dec 1 2017

Fingerprint

Young Adult
Sleep
Neoplasms
Therapeutics
Sleep Initiation and Maintenance Disorders
Quality of Life
Survivors
Electronic Health Records

All Science Journal Classification (ASJC) codes

  • Oncology
  • Pediatrics, Perinatology, and Child Health

Cite this

@article{ffb22eaebafa464a876fb06cc86a513d,
title = "Sleep in Adolescents and Young Adults in the Year after Cancer Treatment",
abstract = "Purpose: Adolescents and young adults (AYA) with cancer are a vulnerable group facing more intense treatments, higher symptom burden, and poorer treatment outcomes relative to younger children. Sleep disruption is common during cancer treatment and sleep problems persist into adulthood for some survivors of AYA cancer. The developmental period of adolescence/emerging adulthood confers greater biological and behavioral risk for insufficient sleep relative to older or younger ages. Thus, understanding AYA sleep disturbances shortly after completing treatment can inform interventions to manage cancer-related symptoms and improve quality of life. Methods: Sixty-one AYA (ages 12-25) within 1 year of finishing cancer treatment completed the Pittsburgh Sleep Quality Index (PSQI) and the Minneapolis-Manchester Quality of Life Instrument-Adolescent Form. Treatment variables were extracted from electronic medical records. Results: Forty-seven percent of participants were classified as {"}poor sleepers,{"} 41{\%} reported prolonged sleep onset latency (>30 minutes), 31{\%} reported sleep efficiency suggestive of insomnia, and 33{\%} slept <8 hours nightly. Age moderated the relationship between time off treatment and PSQI total score: for younger AYA the relationship was positive and for older AYA the relationship was negative. Better sleep and higher quality of life were strongly related (r =-0.57, p < 0.001). Conclusions: For almost half of AYA cancer survivors studied, sleep is disrupted as indicated by long sleep-onset latencies, sleep efficiency suggestive of insomnia, and inadequate total sleep time. Screening for sleep disturbances after AYA complete cancer therapy may reduce the impact of sleep on quality of life and identify those at risk for insomnia.",
author = "Lauren Daniel and Richa Aggarwal and Schwartz, {Lisa A.}",
year = "2017",
month = "12",
day = "1",
doi = "https://doi.org/10.1089/jayao.2017.0006",
language = "English (US)",
volume = "6",
pages = "560--567",
journal = "Journal of Adolescent and Young Adult Oncology",
issn = "2156-5333",
publisher = "Mary Ann Liebert Inc.",
number = "4",

}

Sleep in Adolescents and Young Adults in the Year after Cancer Treatment. / Daniel, Lauren; Aggarwal, Richa; Schwartz, Lisa A.

In: Journal of Adolescent and Young Adult Oncology, Vol. 6, No. 4, 01.12.2017, p. 560-567.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Sleep in Adolescents and Young Adults in the Year after Cancer Treatment

AU - Daniel, Lauren

AU - Aggarwal, Richa

AU - Schwartz, Lisa A.

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Purpose: Adolescents and young adults (AYA) with cancer are a vulnerable group facing more intense treatments, higher symptom burden, and poorer treatment outcomes relative to younger children. Sleep disruption is common during cancer treatment and sleep problems persist into adulthood for some survivors of AYA cancer. The developmental period of adolescence/emerging adulthood confers greater biological and behavioral risk for insufficient sleep relative to older or younger ages. Thus, understanding AYA sleep disturbances shortly after completing treatment can inform interventions to manage cancer-related symptoms and improve quality of life. Methods: Sixty-one AYA (ages 12-25) within 1 year of finishing cancer treatment completed the Pittsburgh Sleep Quality Index (PSQI) and the Minneapolis-Manchester Quality of Life Instrument-Adolescent Form. Treatment variables were extracted from electronic medical records. Results: Forty-seven percent of participants were classified as "poor sleepers," 41% reported prolonged sleep onset latency (>30 minutes), 31% reported sleep efficiency suggestive of insomnia, and 33% slept <8 hours nightly. Age moderated the relationship between time off treatment and PSQI total score: for younger AYA the relationship was positive and for older AYA the relationship was negative. Better sleep and higher quality of life were strongly related (r =-0.57, p < 0.001). Conclusions: For almost half of AYA cancer survivors studied, sleep is disrupted as indicated by long sleep-onset latencies, sleep efficiency suggestive of insomnia, and inadequate total sleep time. Screening for sleep disturbances after AYA complete cancer therapy may reduce the impact of sleep on quality of life and identify those at risk for insomnia.

AB - Purpose: Adolescents and young adults (AYA) with cancer are a vulnerable group facing more intense treatments, higher symptom burden, and poorer treatment outcomes relative to younger children. Sleep disruption is common during cancer treatment and sleep problems persist into adulthood for some survivors of AYA cancer. The developmental period of adolescence/emerging adulthood confers greater biological and behavioral risk for insufficient sleep relative to older or younger ages. Thus, understanding AYA sleep disturbances shortly after completing treatment can inform interventions to manage cancer-related symptoms and improve quality of life. Methods: Sixty-one AYA (ages 12-25) within 1 year of finishing cancer treatment completed the Pittsburgh Sleep Quality Index (PSQI) and the Minneapolis-Manchester Quality of Life Instrument-Adolescent Form. Treatment variables were extracted from electronic medical records. Results: Forty-seven percent of participants were classified as "poor sleepers," 41% reported prolonged sleep onset latency (>30 minutes), 31% reported sleep efficiency suggestive of insomnia, and 33% slept <8 hours nightly. Age moderated the relationship between time off treatment and PSQI total score: for younger AYA the relationship was positive and for older AYA the relationship was negative. Better sleep and higher quality of life were strongly related (r =-0.57, p < 0.001). Conclusions: For almost half of AYA cancer survivors studied, sleep is disrupted as indicated by long sleep-onset latencies, sleep efficiency suggestive of insomnia, and inadequate total sleep time. Screening for sleep disturbances after AYA complete cancer therapy may reduce the impact of sleep on quality of life and identify those at risk for insomnia.

UR - http://www.scopus.com/inward/record.url?scp=85038354033&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85038354033&partnerID=8YFLogxK

U2 - https://doi.org/10.1089/jayao.2017.0006

DO - https://doi.org/10.1089/jayao.2017.0006

M3 - Article

VL - 6

SP - 560

EP - 567

JO - Journal of Adolescent and Young Adult Oncology

JF - Journal of Adolescent and Young Adult Oncology

SN - 2156-5333

IS - 4

ER -